Boehringer Ingelheim [clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f]
Boehringer Ingelheim [clinicaltrials_resource:1f5af28df428803ccefd08f103ea82a2]Peter M. Glassman, MD, PhD [clinicaltrials_resource:b09c34fa8aaab21d8eb226e2109154a3]Boehringer Ingelheim [clinicaltrials_resource:c2d6ae4ee1947bef2d8be89e863f6717]Boehringer Ingelheim Study Coordinator [clinicaltrials_resource:f60a005203c55dd9a26c35275c91672c]
affiliation [clinicaltrials_vocabulary:affiliation]
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [clinicaltrials:NCT00034840]clinicaltrials:NCT00153062A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) [clinicaltrials:NCT00168792]clinicaltrials:NCT00262600clinicaltrials:NCT00523991clinicaltrials:NCT00525512clinicaltrials:NCT00563381clinicaltrials:NCT00621855clinicaltrials:NCT00772538clinicaltrials:NCT00776984clinicaltrials:NCT00954447clinicaltrials:NCT00996658clinicaltrials:NCT01011868Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example [clinicaltrials:NCT01036763]clinicaltrials:NCT01050062clinicaltrials:NCT01072396clinicaltrials:NCT01084005clinicaltrials:NCT01087502clinicaltrials:NCT01122680BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). [clinicaltrials:NCT01131676]clinicaltrials:NCT01152450clinicaltrials:NCT01159600clinicaltrials:NCT01164501clinicaltrials:NCT01167881clinicaltrials:NCT01172808clinicaltrials:NCT01172821clinicaltrials:NCT01177813clinicaltrials:NCT01183013clinicaltrials:NCT01193218clinicaltrials:NCT01194830clinicaltrials:NCT01204294clinicaltrials:NCT01210001clinicaltrials:NCT01214239clinicaltrials:NCT01215097clinicaltrials:NCT01233284CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes [clinicaltrials:NCT01243424]clinicaltrials:NCT01257230clinicaltrials:NCT01277523clinicaltrials:NCT01289990clinicaltrials:NCT01306214
collaborator [clinicaltrials_vocabulary:collaborator]
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) [clinicaltrials:NCT00000649]An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease [clinicaltrials:NCT00002166]An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. [clinicaltrials:NCT00002194]A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell [clinicaltrials:NCT00002323]The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease [clinicaltrials:NCT00002324]The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs [clinicaltrials:NCT00002368]The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine [clinicaltrials:NCT00002381]Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [clinicaltrials:NCT00003328]Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [clinicaltrials:NCT00034840]Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) [clinicaltrials:NCT00034853]Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals [clinicaltrials:NCT00034866]A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis [clinicaltrials:NCT00042068]clinicaltrials:NCT00054717Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients [clinicaltrials:NCT00056641]Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients [clinicaltrials:NCT00060801]Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection [clinicaltrials:NCT00062660]clinicaltrials:NCT00076999Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [clinicaltrials:NCT00096616]Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection [clinicaltrials:NCT00097799]Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00106821]Dose Finding Study in COPD [clinicaltrials:NCT00122434]High Dose Trial in COPD [clinicaltrials:NCT00128440]Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients [clinicaltrials:NCT00129038]A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension [clinicaltrials:NCT00133185]Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) [clinicaltrials:NCT00133198]A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients. [clinicaltrials:NCT00144105]Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV [clinicaltrials:NCT00144157]clinicaltrials:NCT00144170A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) [clinicaltrials:NCT00144183]12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) [clinicaltrials:NCT00144196]Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome [clinicaltrials:NCT00144209]Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy [clinicaltrials:NCT00144222]Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue [clinicaltrials:NCT00144235]A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions [clinicaltrials:NCT00144248]An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects [clinicaltrials:NCT00144261]Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis [clinicaltrials:NCT00144274]Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options [clinicaltrials:NCT00144287]clinicaltrials:NCT00144300A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00144326]clinicaltrials:NCT00144339
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [clinicaltrials:NCT00034840]Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) [clinicaltrials:NCT00034853]Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals [clinicaltrials:NCT00034866]A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis [clinicaltrials:NCT00042068]clinicaltrials:NCT00054717Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients [clinicaltrials:NCT00056641]Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients [clinicaltrials:NCT00060801]Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection [clinicaltrials:NCT00062660]clinicaltrials:NCT00076999Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [clinicaltrials:NCT00096616]Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection [clinicaltrials:NCT00097799]Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00106821]Dose Finding Study in COPD [clinicaltrials:NCT00122434]High Dose Trial in COPD [clinicaltrials:NCT00128440]Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients [clinicaltrials:NCT00129038]A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension [clinicaltrials:NCT00133185]Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) [clinicaltrials:NCT00133198]A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients. [clinicaltrials:NCT00144105]Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV [clinicaltrials:NCT00144157]clinicaltrials:NCT00144170A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) [clinicaltrials:NCT00144183]12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) [clinicaltrials:NCT00144196]Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome [clinicaltrials:NCT00144209]Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy [clinicaltrials:NCT00144222]Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue [clinicaltrials:NCT00144235]A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions [clinicaltrials:NCT00144248]An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects [clinicaltrials:NCT00144261]Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis [clinicaltrials:NCT00144274]Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options [clinicaltrials:NCT00144287]clinicaltrials:NCT00144300A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00144326]clinicaltrials:NCT00144339The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects [clinicaltrials:NCT00146289]clinicaltrials:NCT00146328Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg [clinicaltrials:NCT00146341]Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction [clinicaltrials:NCT00148460]A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) [clinicaltrials:NCT00148486]Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis [clinicaltrials:NCT00148499]A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations [clinicaltrials:NCT00148512]A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) [clinicaltrials:NCT00152958]
source [clinicaltrials_vocabulary:source]
Boehringer Ingelheim [clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f]
Bio2RDF identifier
5d012cfae6e8b67d8437e7145ea9a68f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f
title
Boehringer Ingelheim
@en
type
label
Boehringer Ingelheim [clinicaltrials_resource:5d012cfae6e8b67d8437e7145ea9a68f]
@en